Last reviewed · How we verify

NCT06034912

Fundus Effects of Repeated Low-Level Red-Light Therapy in Chinese Myopic Minors: A Randomized Controlled Clinical Trial

Status unknown NA Last updated 5 December 2023
What this trial tests

NA trial testing Low-Intensity Red Light Therapy in Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis) in 70 participants. Status unknown.

Timeline
28 June 2023
Primary endpoint
29 March 2024
31 May 2024

Quick facts

Lead sponsorZhongshan Ophthalmic Center, Sun Yat-sen University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment70
Start date28 June 2023
Primary completion29 March 2024
Estimated completion31 May 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

Adults 7 to 17, any sex, with Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Research Objective: The primary objective is to investigate the short-term effects of repetitive low-intensity red light therapy on the fundus of the eyes of underage individuals with myopia. 2. Research Design: This experiment employs a prospective, single-center, randomized, controlled clinical research design. 3. Primary Outcome: Changes in macular sensitivity (microperimetry). 4. Recruitment and Participant Information: The study population consists of individuals aged 7 to 17 years old. It is anticipated that there will be 35 participants in both the control group and the experimental group. 5. Trial Location: Zhongshan Ophthalmic Center, Sun Yat-sen University. Contact Information: Shuyu Chen, +190805155537, chenshuyu980916@163.com.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06034912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing